Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
boston blog main
boston top stories
4
×
life sciences
national blog main
national top stories
biotech
boston
new york blog main
cancer
clinical trials
fda
new york top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
akcea therapeutics
alnylam pharmaceuticals
arena pharmaceuticals
barry greene
beam therapeutics
biotech week boston
boston university
boulder/denver blog main
boulder/denver top stories
bristol-myers squibb
broad institute
bwb
cardiovascular disease
christina isacson
cindy perettie
circulation
colorectal cancer
crispr
dan ollendorf
david liu
detroit blog main
detroit top stories
digital health
drugs
What
medicine
4
×
patients
4
×
fda
market
ago
alnylam
approve
awaits
award
benefiting
biological
boston
cancer
center
coming
community
complexity
crossed
decades
decision
diagnostics
digital
discovered
drug
eisai
finalists
fingers
flags
friday
glimcher
groundbreaking
headline
healthcare
higher
historic
incidence
industries
keynote
laurie
life
Language
unset
Current search:
medicine
×
patients
×
" boston top stories "
×
@xconomy.com
4 years ago
Eisai Pulls Weight Loss Drug From Market After FDA Flags Cancer Risks
@xconomy.com
4 years ago
Laurie Glimcher To Headline Xconomy Keynote Series in Boston in September
@xconomy.com
5 years ago
Digital Tools, Online Community & More: Patient Partnership Award Finalists
@xconomy.com
5 years ago
Patients Have “Fingers Crossed” As Alnylam Awaits Historic FDA Decision
